Skip to main content

KORU Medical Systems, Inc.

corporate_fare Company Profile

KORU Medical Systems, Inc.

KRMD·NASDAQ·Industrial Applications And Services·CIK 0000704440

KORU Medical develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions. The company primarily serves the subcutaneous drug delivery market, adhering to the United States Food and Drug Administration (FDA) quality and regulatory system and international quality system management standards. KORU Medical focuses on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60® Syringe Driver, the FreedomEdge® Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets™, and Precision Flow Rate Tubing™. Revenues are generated from three business sources: domestic core (US and Canada), international core, and pharma services and clinical trials. Domestic and international core revenues come from sales of syringe drivers, tubing, and needles (Product Revenue) for subcutaneous drugs cleared by the FDA for use with the FREEDOM System. The primary use is for immunoglobulin delivery to treat Primary Immunodeficiency Diseases (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Pharma services and clinical trials revenues include Product Revenue for feasibility/clinical trials (pre-clinical studies, Phase I, Phase II, Phase III) for biopharmaceutical companies, as well as non-recurring engineering services (NRE) revenues for product innovation, testing, and registration services to customize the FREEDOM System for clinical and commercial use. The company was originally incorporated in March 1980.

KORU Medical Systems, Inc. (NASDAQ:KRMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 16 items for KRMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for KRMD spans 10-Q, 8-K, 4, DEF 14A.

Recent high-impact activity:

  • KORU 10-Q: Q3 Revenue Up 11% to $11.6M, Gross Margin 65.2%, Cash Slips to $7.4M
  • KORU Posts Second Straight Profitable Quarter, Lifts Margin and Cash Guidance
  • KORU Medical Swings to Q2 Profit, Raises Gross Margin Outlook
  • KORU Medical Systems Extends Key Manufacturing Agreement to 2031, Mandates Second Production Site
  • Shareholders Approve Significant Increase in Equity Incentive Plan

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$41.13M
Net Income
-$2.64M
Diluted EPS
-$0.06
Op. Cash Flow
$462.4K
Free Cash Flow
-$470.11K
Gross Profit
$25.6M
Operating Income
-$2.97M
Cash & Equivalents
$8.87M
Debt / Equity
0.00×
Net Margin
-6.4%
Shares Outstanding
46.37M sh
Source: 10-K · filed 2026-03-12 · accession 0001161697-26-000052

Short Interest & Short Volume

6.55 days to cover

FINRA reported short interest of 861,413 shares in KRMD as of the October 30, 2026 settlement, a 3.0% decrease from the prior period — about 6.5 days to cover at its recent average daily volume. On November 20, 2026, 55.8% of KRMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)861,413 shares as of October 30, 2026
Change vs prior period▼ 3.0%
Days to cover6.55 at avg daily volume of 131,562
Daily short volume (FINRA facilities)55.8% of 111,866 shares on November 20, 2026
5-day average short volume46.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with K →
$3.21 +0.63% today
52-week range · as of 2026-11-10 $2.86 – $6.61
Market cap
$138.37M
Volume
320.9K (1.6× avg)
3-mo avg 205.3K
Live data · 2026-11-22 04:38 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed KRMD - Latest Insights

KRMD
Nov 10, 2026, 4:44 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.16
Real-time Price: $3.21 info
Change: +$0.0455 (+1%) info
Market Cap: $138.367M info
KRMD
Nov 10, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $3.16
Real-time Price: $3.21 info
Change: +$0.050 (+2%) info
Market Cap: $138.367M info
KRMD
Aug 05, 2026, 4:50 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.90
Real-time Price: $3.21 info
Change: -$0.690 (-18%) info
Market Cap: $138.367M info
KRMD
Jun 30, 2026, 4:57 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.20
Real-time Price: $3.21 info
Change: -$0.990 (-24%) info
Market Cap: $138.367M info
KRMD
May 21, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.14
Real-time Price: $3.21 info
Change: -$0.930 (-22%) info
Market Cap: $138.367M info
KRMD
May 20, 2026, 4:02 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $4.04
Real-time Price: $3.21 info
Change: -$0.830 (-21%) info
Market Cap: $138.367M info
KRMD
May 06, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.19
Real-time Price: $3.21 info
Change: -$0.980 (-23%) info
Market Cap: $138.367M info
KRMD
May 06, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.96
Real-time Price: $3.21 info
Change: -$0.750 (-19%) info
Market Cap: $138.367M info
KRMD
Apr 09, 2026, 4:03 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $4.37
Real-time Price: $3.21 info
Change: -$1.16 (-27%) info
Market Cap: $138.367M info
KRMD
Apr 03, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.32
Real-time Price: $3.21 info
Change: -$1.11 (-26%) info
Market Cap: $138.367M info
KRMD
Mar 13, 2026, 9:44 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.20
Real-time Price: $3.21 info
Change: -$0.990 (-24%) info
Market Cap: $138.367M info
KRMD
Mar 12, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $3.21 info
Change: -$0.890 (-22%) info
Market Cap: $138.367M info
KRMD
Mar 12, 2026, 4:09 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $3.21 info
Change: -$0.890 (-22%) info
Market Cap: $138.367M info
KRMD
Mar 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $3.21 info
Change: -$0.890 (-22%) info
Market Cap: $138.367M info
KRMD
Feb 13, 2026, 4:56 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.67
Real-time Price: $3.21 info
Change: -$1.46 (-31%) info
Market Cap: $138.367M info
KRMD
Jan 12, 2026, 10:25 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.36
Real-time Price: $3.21 info
Change: -$2.15 (-40%) info
Market Cap: $138.367M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets